Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
Sydney Sweeney is returning in 'The Housemaid's Secret': What to know about 'The Housemaid' sequel- New funding transforms lives by expanding electricity access across Africa
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- Experience Sports in Dubai: A Daredevil's Aide
- Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
- With Obamacare premium hikes, more people opting for no coverage or cheaper plans
- British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- Get Cooking: 15 Speedy and Heavenly Recipes for Occupied Individuals
